GTBP
GTBP
NASDAQ · Biotechnology

Gt Biopharma Inc

$0.32
-0.03 (-7.96%)
As of May 16, 2:28 AM ET ·
Financial Highlights (FY 2025)
Revenue
4.23M
Net Income
-163,651
Gross Margin
31.7%
Profit Margin
-3.9%
Rev Growth
+8.4%
D/E Ratio
0.23
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 31.7% 31.7% 31.7%
Operating Margin -4.6% -4.2% -4.1%
Profit Margin -3.9% -4.7% -4.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.23M 4.16M 3.54M
Gross Profit 1.34M 1.32M 1.12M
Operating Income -195,035 -172,810 -146,057
Net Income -163,651 -194,157 -147,578
Gross Margin 31.7% 31.7% 31.7%
Operating Margin -4.6% -4.2% -4.1%
Profit Margin -3.9% -4.7% -4.2%
Rev Growth +8.4% +2.1% +5.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.36M 2.22M 1.86M
Total Equity 10.06M 10.08M 9.46M
D/E Ratio 0.23 0.22 0.20
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -229,901 -240,916 -206,498
Free Cash Flow -133,630 -165,029 -157,801